Related Experiment Video
Updated: Apr 30, 2026

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
Immunosurveillance of senescent cancer cells by natural killer cells
Alexandre Iannello1, David H Raulet1
1Department of Molecular and Cell Biology; University of California at Berkeley; Berkeley, CA USA ; Cancer Research Laboratory; University of California at Berkeley; Berkeley, CA USA.
Abstract:
We recently dissected how senescent tumors can trigger complementing signaling pathways that mobilize natural killer (NK) cells to eliminate malignant cells. In addition to cell-intrinsic effects on proliferation, senescence induces the production of chemokine (C-C motif) ligand 2 (CCL2), which recruits NK cells to mediate direct tumoricidal effects. Hence, senescence activates a cancer cell-extrinsic oncosuppression program.
Insights
Tumor senescence triggers pathways that recruit natural killer (NK) cells to fight cancer. This process involves chemokine ligand 2 (CCL2) production, activating an external anti-cancer defense program.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Tumor cells can enter a state of senescence, a stable cell cycle arrest.
- Senescence has been recognized for its complex roles in cancer, including both tumor suppression and promotion.
Purpose of the Study:
- To investigate the mechanisms by which senescent tumors mobilize immune cells for cancer elimination.
- To elucidate the role of specific signaling pathways and chemokines in this anti-tumor immune response.
Main Methods:
- Analysis of signaling pathways activated during tumor cell senescence.
- Assessment of chemokine production by senescent tumor cells.
- Investigation of natural killer (NK) cell recruitment and tumoricidal activity in response to senescent tumor cues.
Main Results:
- Senescent tumors activate specific signaling pathways that enhance NK cell mobilization.
- Senescence induces the production of chemokine (C-C motif) ligand 2 (CCL2).
- CCL2 recruits NK cells, which then exert direct tumoricidal effects.
Conclusions:
- Tumor cell senescence initiates a cancer cell-extrinsic oncosuppression program.
- Senescence-induced CCL2 production is a key mechanism for recruiting NK cells to eliminate tumors.
- Targeting senescence pathways may represent a novel immunotherapy strategy for cancer treatment.
Related Concept Videos
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Replicative Cell Senescence
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Tumor Immunotherapy

